军事知识服务平台
β受体阻滞剂对脓毒性休克患者疗效的荟萃分析
Effects ofβ-blockers in patients with septic shock:a meta analysis
摘要 目的:系统评价β受体阻滞剂对脓毒性休克患者的作用。方法检索PubMed、EMBASE、Cochrane Library及中国知网CNKI、万方数据库自建库至2015年10月发表的有关β受体阻滞剂对脓毒性休克患者作用的文献,采用STATA12.0软件进行荟萃分析。采用随机效应模型进行合并分析。结果最终得到符合纳入标准的文献7篇,累计392例。其中3篇随机对照研究( RCT),4篇自身对照研究。自身对照研究荟萃分析结果显示:与基线水平相比,脓毒性休克患者在应用β受体阻滞剂24 h后,心率显著降低[标准化均数差( SMD)=-2.51,95%CI:-4.32~-0.70, P =0.007],血清乳酸水平降低( SMD=-0.34,95%CI:-0.67~-0.02, P=0.039)。但平均动脉压(SMD=0.01,95%CI:-0.42~0.44,P=0.969)、心脏指数(SMD=-0.35,95%CI:-1.15~0.44, P=0.385)及去甲肾上腺素的用量(SMD=-0.06,95%CI:-0.38~0.27,P=0.726)变化不大。 RCT的分析结果显示:与常规治疗组相比,联用艾司洛尔组各时间点心率均显著下降(均P<0.001),28 d病死率降低(RR=0.60,95%CI:0.48~0.75,P<0.001),自用药后24 h起肌钙蛋白 I 降低( P<0.001),其他血流动力学及心功能指标如平均动脉压、心脏指数、每搏输出量指数变化不大(均P>0.05)。结论现有证据表明,β受体阻滞剂可以降低脓毒性休克患者的心率、肌钙蛋白I水平和28 d病死率,对平均动脉压、心脏指数、每搏输出量指数等影响不大。可以开展大规模、多中心RCT,验证β受体阻滞剂对脓毒症休克的疗效。
Abstract:
Objective To evaluate the effect ofβ-blockers in patients with septic shock.Methods PubMed, EMBASE, Cochrane central registration of controlled trials, CNKI and Wanfang Data were searched to identify relevant studies from inception to October 2015.Statistical analysis was performed using STATA 12.0.The random effects model was used due to wide clinical variability across the trials.Results After application of the inclusion criteria, 7 trials with 392 patients were included, involving 3 randomized controlled trials ( RCT) and 4 quasi-experiments.The results of the meta-analysis for the quasi-experiments showed that compared with baseline, heart rates (standardized mean difference (SMD)=-2.51, 95%CI:-4.32--0.70, P=0.007) and lactate levels (SMD=-0.34, 95%CI:-0.67--0.02, P=0.039) significantly decreased, while no significant differences were seen for mean arterial pressure ( SMD=0.01, 95%CI:-0.42-0.44, P=0.969), cardiac index (SMD=-0.35, 95%CI:-1.15-0.44, P=0.385) or norepinephrine requirements ( SMD =-0.06, 95%CI: -0.38 -0.27, P =0.726 ) after 24-hour therapy.Among randomized controlled trials,β-blockers, compared with standard care, was associated with reductions in heart rates (P<0.001) , 28-day mortality (RR=0.60, 95%CI:0.48-0.75, P<0.001) and troponin I levels ( P <0.001 ) .While no differences were found between the two groups in other&nbsp;hemodynamic and cardiac function variables, such as mean arterial pressure, cardiac index or stroke volume index (P>0.05).Conclusions The currently available evidence indicates that the use of β-blockers is associated with a significant decrease in heart rate, troponin I levels and 28-day mortality in patients with septic shock, while mean arterial pressure, cardiac index and stroke volume index might remain unchanged.Large scale, muti-center RCTs need to be carried out to confirm the effects of β-blockers in patients with septic shock.
Author: Yu Yanwu Sun Tongwen Wan Youdong Liu Ziqi Kan Quancheng
作者单位: 450052,郑州大学第一附属医院综合重症监护室 河南省高等学校临床医学重点学科开放实验室
刊 名 中华医学杂志 ISTICPKU
年,卷(期): 2016, (7)
机标分类号: R97 R54
在线出版日期: 2016年4月14日
基金项目: (豫卫科2010-52):河南省卫生科技创新人才工程专项基金(16IRTSTHN021):河南省高校科技创新团队(2010-52):Fund programInnovative Investigators Project Grant from the Health Bureau of Henan Provice(in Science and Technology) in University of Henan Province (16IRTSTHN021):Program for Innovative Reseach Team,